Johnson & Johnson (JNJ)
206.54
+6.58
(+3.29%)
USD |
NYSE |
Dec 10, 16:00
206.84
+0.30
(+0.15%)
Pre-Market: 07:20
Johnson & Johnson Cash from Investing (Quarterly): -542.00M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amgen, Inc. | -414.00M |
| Gilead Sciences, Inc. | -427.00M |
| Eli Lilly & Co. | -2.983B |
| Regeneron Pharmaceuticals, Inc. | -402.90M |
| Protagonist Therapeutics, Inc. | -58.56M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 9.169B |
| Cash from Financing (Quarterly) | -8.927B |
| Free Cash Flow | 20.46B |
| Free Cash Flow Per Share (Quarterly) | 3.292 |
| Free Cash Flow to Equity (Quarterly) | 12.96B |
| Free Cash Flow to Firm (Quarterly) | 8.255B |
| Free Cash Flow Yield | 4.09% |